Earth Life Sciences Inc.
CLTS · OTC
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Market Cap | $3 | $5 | $2 | $3 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $3 | $6 | $2 | $3 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | $0 | -$2 | -$0 | -$0 |
| % Margin | – | – | – | – |
| Net Income | -$2 | -$2 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.003 | -0.004 | -0 | -0.001 |
| % Growth | 23.8% | -2,000% | 84.6% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | $0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | $0 |